Abstract:Min Gu, 1, 2, &ast Xiaohui Zhang, 1, 2, &ast Fang Ni, 1, 2 Jue Wang, 1, 2 Wenying Xia, 1, 2 Yanfei Lu 1, 2 1 Department of Laboratory Medicine, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, People's Republic of China; 2 National Key Clinical Department of Laboratory Medicine, Nanjing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yanfei Lu; Wenying Xia, Department of Laboratory Medicine, Jiangsu Province Hospital, Street No. 300, Guangzhou, 210029, People's Republic of China, Tel +8625-6830-6287, Email ; Purpose: To explore the characteristics of the pathogen distribution and drug resistance in bloodstream infections (BSIs) during the COVID-19 pandemic in a tertiary hospital in eastern China, and to compare them with those before the pandemic. Patients and Methods: Non-repetitive strain data of BSIs were retrospectively obtained before the COVID-19 pandemic (Pre-Pandemic, n=2698) and during the COVID-19 pandemic (Pandemic, n=2922), the distribution of pathogens and drug resistance were compared between the two groups. Results: The main pathogens of BSIs were Gram-negative bacteria (57.91%), followed by Gram-positive bacteria (32.58%), fungi and anaerobic bacteria accounting for 5.48% and 3.39%, respectively. Escherichia coli, Klebsiella pneumoniae and Staphylococcus aureus were the top 3 isolates. The proportion of Serratia marcescens, Enterobacter aerogenes, Enterococcus faecium, Enterococcus faecalis and Candida tropicalis were significantly increased, while those of Pseudomonas aeruginosa, Streptococcus sanguinis and Streptococcus pneumoniae were significantly decreased when compared to the Pre-Pandemic ( P < 0.05). Carbapenem-resistant Enterobacterales (CRE) significantly elevated during the Pandemic (17.4% vs 14.4%, P =0.041); the detection of carbapenem-resistant Pseudomonas aeruginosa (CRPA) significantly ascended (39.0% vs 24.4%, P =0.016); and the proportion of carbapenem-resistant Acinetobacter baumannii (CRAB) maintained stable (78.8%). Gram-positive bacteria had the lowest resistance to linezolid, vancomycin and tigecycline, which remained a stable trend with the Pre-Pandemic (< 5.0%). The isolate rates of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) were 38.9% and 1.0%, respectively. Staphylococcus aureus showed a decrease in the isolation rate of vancomycin minimum inhibitory concentration (MIC) ≤ 0.5 μg/mL ( χ 2 =7.676, P =0.006) and an increase with vancomycin MIC=1 μg/mL ( χ 2 =9.008, P =0.003). Conclusion: The pathogen distribution and drug resistance of BSIs during the COVID-19 pandemic were transformed from Pre-Pandemic and accompanied by increasing bacterial resistance. Clinical management of antibiotic application and infection control should be strengthened. Keywords: COVID-19 pandemic, bloodstream infection, pathogen distribution, antibiotic resistance Bloodstream infections (BSIs) are frequent life-threatening infectious diseases clinically, the incidence of which is approximately 113–204 per 100,000 population, similar to that of stroke or venous thrombosis. 1 The disease has a mortality rate of 18%-35% 2 and may contribute to prolonged hospitalizations and severe complications, imposing a heavy burden on patients and healthcare systems. 3,4 Due to the widespread application of modern invasive diagnostic and therapeutic technologies and the inappropriate use of antibiotics, the incidence rate of BSIs has been increasing. 5 Antibiotic therapy is an effective method for BSIs, and timely control of BSIs is crucial for patients' prognosis. Blood culture is currently the gold standard for diagnosing BSIs. 6 Clinicians typically choose broad-spectrum antibiotics empirically based on the blood culture results and then adjust the type and dosage of antibiotics according to antimicrobial susceptibility testing in vitro. 7 The distribution of pathogen and drug resistance in patients with BSIs has general heterogeneity. Therefore, understanding the distribution of pathogenic bacteria and drug resistance characteristics of BSIs in different periods, regions, and even populations is essential for empirical therapy and antibiotic management. Coronavirus disease 2019 (COVID-19) is an aggressive respiratory infectious disease caused by the novel severe acute respirator -Abstract Truncated-

A-289 Emergence of Unusual Non-Fermentative Gram-Negative Bacilli Associated to COVID-19 Period at Brazilian Hospitals

A-255 Microbiological Profile and Frequency Distribution of Uropathogens in Brazilian Public Hospitals. Data From a Clinical Laboratory (2018-2023)

A-288 Active Surveillance Cultures: Frequency of Microorganisms and Phenotypic Resistance Profile From Brazilian Public Hospitals After COVID-19 Pandemic Peak

Clinical and microbiological features of positive blood culture episodes caused by non-fermenting gram-negative bacilli other than Pseudomonas and Acinetobacter species (2020-2023)

Changing patterns of bacterial profile and antimicrobial resistance in high-risk patients during the COVID-19 pandemic at a tertiary oncology hospital

The "COVID effect" in culture-based clinical microbiology: Changes induced by COVID-19 pandemic in a Hungarian tertiary care center

The impact of COVID-19 on microbiological profile and antibiotic consumption in ICU: a retrospective study in an infectious disease hospital in Brazil

Bacterial coinfections in COVID-19-hospitalized patients

Pathogen Species Is Associated With Mortality in Nosocomial Bloodstream Infection in Patients With COVID-19

Clinical and microbiological profile of healthcare-associated infections in a tertiary hospital: Comparison between a cohort of hospitalized patients during pre-pandemic and COVID-19 pandemic periods

Clinical characteristics and risk factors for the isolation of multi-drug-resistant Gram-negative bacteria from critically ill patients with COVID-19

A comparative study of multidrug resistant bacteria (MDRB) isolated from various patients in different wards of a hospital during post Covid-19

Antimicrobial resistance patterns among critical priority pathogens in an intensive care unit at a tertiary hospital in Egypt: a descriptive analysis comparing pre- and COVID-19 eras

Early coronavirus disease 2019 (COVID-19) pandemic effects on individual-level risk for healthcare-associated infections in hospitalized patients

Impact of antimicrobial stewardship in organisms causing nosocomial infection among COVID-19 critically ill adults

A-290 Prevalence and Antimicrobial Resistance Pattern of Microorganisms Recovered From Bloodstream Infections From Public Hospitals of São Paulo City, Brazil

Pattern of Bacterial and Fungal Infections among Hospitalized Patients with COVID-19 versus non COVID-19 Community Acquired Pneumonia

Persistent carbapenem resistance in mechanically ventilated ICU patients: A before-and-after analysis of the COVID-19 surge

Increased 30-day all-cause mortality associated with Gram-negative bloodstream infections in England during the COVID-19 pandemic

Characterization of the Pathogen Distribution and Drug Resistance in Bloodstream Infections During COVID-19 Pandemic in a Tertiary Hospital in Eastern China: Comparison with the Pre-Pandemic Period

A Change in Nosocomial Infections among Surgical ICU Patients in the COVID-19 Era and MALDI-TOF Mass Spectrometry-A Cross-Sectional Study